976 Shares in Axon Enterprise, Inc (NASDAQ:AXON) Purchased by Virtu Financial LLC

Key Points

• Virtu Financial LLC acquired a new stake in Axon Enterprise, purchasing 976 shares valued at approximately $513,000 in the first quarter.
• Several other institutions also increased their holdings in Axon Enterprise, with 79.08% of the stock now owned by institutional investors and hedge funds.
• Axon Enterprise recently reported quarterly earnings of $2.12 EPS, exceeding analyst estimates and marking a 32.6% increase in revenue year-over-year.

Virtu Financial LLC purchased a new position in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 976 shares of the biotechnology company's stock, valued at approximately $513,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. LaSalle St. Investment Advisors LLC raised its stake in Axon Enterprise by 2.1% during the first quarter. LaSalle St. Investment Advisors LLC now owns 777 shares of the biotechnology company's stock worth $408,000 after purchasing an additional 16 shares during the period. Pinion Investment Advisors LLC raised its stake in Axon Enterprise by 3.0% during the first quarter. Pinion Investment Advisors LLC now owns 649 shares of the biotechnology company's stock worth $341,000 after purchasing an additional 19 shares during the period. Kentucky Retirement Systems raised its stake in Axon Enterprise by 0.4% during the first quarter. Kentucky Retirement Systems now owns 4,953 shares of the biotechnology company's stock worth $2,605,000 after purchasing an additional 19 shares during the period. WCM Investment Management LLC raised its stake in shares of Axon Enterprise by 0.8% in the 1st quarter. WCM Investment Management LLC now owns 2,441 shares of the biotechnology company's stock valued at $1,306,000 after acquiring an additional 19 shares during the period. Finally, Sheaff Brock Investment Advisors LLC raised its stake in shares of Axon Enterprise by 0.5% in the 1st quarter. Sheaff Brock Investment Advisors LLC now owns 3,561 shares of the biotechnology company's stock valued at $1,873,000 after acquiring an additional 19 shares during the period. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Stock Up 0.6%

Shares of NASDAQ:AXON traded up $4.41 during trading hours on Friday, reaching $754.24. The stock had a trading volume of 583,176 shares, compared to its average volume of 783,867. Axon Enterprise, Inc has a 1 year low of $346.71 and a 1 year high of $885.91. The firm's 50 day moving average is $773.85 and its 200-day moving average is $670.30. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95. The stock has a market capitalization of $59.21 billion, a price-to-earnings ratio of 186.23, a P/E/G ratio of 27.68 and a beta of 1.36.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, beating analysts' consensus estimates of $1.54 by $0.58. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The company had revenue of $668.54 million for the quarter, compared to the consensus estimate of $641.77 million. During the same period in the prior year, the firm posted $1.20 EPS. The company's quarterly revenue was up 32.6% compared to the same quarter last year. Research analysts predict that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on AXON shares. The Goldman Sachs Group boosted their price target on shares of Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a research note on Wednesday, May 14th. Craig Hallum raised shares of Axon Enterprise from a "hold" rating to a "buy" rating and set a $900.00 price target on the stock in a research note on Tuesday, August 5th. Barclays boosted their price target on shares of Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a research note on Friday, May 9th. Bank of America boosted their price target on shares of Axon Enterprise from $895.00 to $1,000.00 and gave the company a "buy" rating in a research note on Wednesday, August 6th. Finally, Raymond James Financial reissued an "outperform" rating and issued a $855.00 price target (up from $645.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Two investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company's stock. Based on data from MarketBeat, Axon Enterprise currently has a consensus rating of "Moderate Buy" and a consensus target price of $837.69.

Insider Transactions at Axon Enterprise

In related news, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction on Monday, August 11th. The shares were sold at an average price of $831.29, for a total value of $8,312,900.00. Following the transaction, the chief executive officer directly owned 3,053,982 shares of the company's stock, valued at $2,538,744,696.78. This trade represents a 0.33% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Michael Garnreiter sold 5,913 shares of the stock in a transaction on Wednesday, June 4th. The shares were sold at an average price of $760.00, for a total transaction of $4,493,880.00. Following the completion of the transaction, the director directly owned 17,740 shares in the company, valued at $13,482,400. This trade represents a 25.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 54,995 shares of company stock worth $41,925,130. Insiders own 4.40% of the company's stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.